Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells

Authors

Dina M. El-Kersh, The British University in EgyptFollow
Yasmeen attia, The British University in EgyptFollow

Document Type

Article

Publication Date

2024

Recommended Citation

El-Kersh, Dina M. and attia, Yasmeen, "Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells" (2024). Pharmacy. 854.
https://buescholar.bue.edu.eg/pharmacy/854